Concepedia

Publication | Open Access

Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer

DOIFull Paper Access

28

Citations

25

References

2022

Year

Ulka N. Vaishampayan, Archana Thakur, Wei Chen, Abhinav Deol, Meera Patel, Kimberlee Dobson, Brenda Dickow, Dana L. Schalk, Amy Schienschang, Sarah A. Whitaker,
Clinical Cancer Research

Abstract

The safety and promising efficacy makes this combination worthy of future investigation in mCRPC.

References

YearCitations

Page 1